Navigation Links
The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009'
Date:12/2/2009

LEXINGTON, Mass. and HEIDELBERG, Germany, Dec. 2 /PRNewswire/ -- febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazine. The company's automated sequence capture technology for high-throughput sequencing was selected due to its exceptional combinations of invention, vision and utility.

The Scientist gathered a panel of expert judges to evaluate a broad range of life science technologies and determined the best innovations to hit the life sciences market in 2009. The winners' list includes a variety of products that capture both intracellular and extracellular processes. HybSelect is a robust and automated method for selecting and enriching high-value target regions from the genome that enables cost-effective massively parallel sequencing.

"Next-Generation-Sequencing (NGS) is an accurate and high-performance technology for diagnostics and has been limited by throughput, cost, data management and automation issues," said Peer Staehler, chief scientific officer of febit. "Instead of analyzing large-sequence stretches of a single genome, researchers using HybSelect are now able to focus on targeted re-sequencing of interesting regions from many different patients in parallel."

HybSelect combines the advantages of microarray-based enrichment with patent protected microfluidic biochip technology and runs on the dedicated, highly automated instrument, the Geniom® RT Analyzer. It allows to conduct large scale clinical studies to identify SNPs and mutations as new biomarkers to receive statistically relevant data.

To read the full article of The Scientist please visit http://www.the-scientist.com/2009/12/1/41/1/

About febit

febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. febit's product portfolio includes various instruments, optimized assays and bioanalytical services, complemented by bioinformatics software and consulting.

The key applications are HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing, and hands-off, amplification free microRNA profiling. Both are taking advantage of the advanced microfluidics of the patented Geniom Biochip to offer the highest degree of automation, flexibility and efficiency available.

For more information, please visit www.febit.com.


          Contact: febit group, Eva Sterzel, eva.sterzel@febit.de,
                              +49 (0)6221 6510-300
                     Russo Partners, Martina Schwarzkopf,
         martina.schwarzkopf@russopartnersllc.com, +1 212 845-4292

SOURCE febit


'/>"/>
SOURCE febit
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research
2. Roche Scientist Recognized for Excellence in Peptide Chemistry
3. New Cardiovascular Biomarker Available for Scientist in North America
4. Scientists Identify Gene for Short Circuiting Excess Mucous in Lung Disease, Common Colds
5. IBM Scientists First to Image the Anatomy of a Molecule
6. Scientists Discover Origin of Malaria
7. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
8. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
9. Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels
10. Scientists Discover Why Teeth Form in a Single Row
11. Scientists Unmask Genetic Markers Associated With Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):